Member of the Association of American Physicians
His main research concerns Internal medicine, Gastroenterology, Cirrhosis, Fatty liver and Nonalcoholic fatty liver disease. His research on Internal medicine often connects related topics like Endocrinology. Arun J. Sanyal interconnects Liver biopsy, Immunology, Model for End-Stage Liver Disease and Hepatitis C virus in the investigation of issues within Gastroenterology.
His Cirrhosis research is multidisciplinary, incorporating elements of Liver disease, Surgery, Hepatocellular carcinoma and Intensive care medicine. His Fatty liver study integrates concerns from other disciplines, such as Apoptosis, Cancer research, Obesity and microRNA. His research in Nonalcoholic fatty liver disease intersects with topics in Odds ratio, Hepatology and Primary biliary cirrhosis.
Arun J. Sanyal mainly focuses on Internal medicine, Gastroenterology, Cirrhosis, Nonalcoholic fatty liver disease and Fatty liver. Arun J. Sanyal regularly links together related areas like Endocrinology in his Internal medicine studies. His Gastroenterology research integrates issues from Placebo, Liver transplantation, Liver biopsy and Hepatitis C.
In his research, Transjugular intrahepatic portosystemic shunt is intimately related to Surgery, which falls under the overarching field of Cirrhosis. The various areas that Arun J. Sanyal examines in his Nonalcoholic fatty liver disease study include Steatosis, Metabolic syndrome, Hepatology and Insulin resistance. His Fatty liver study results in a more complete grasp of Disease.
Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Steatohepatitis and Cirrhosis are his primary areas of study. He studied Internal medicine and Endocrinology that intersect with Agonist. His studies in Gastroenterology integrate themes in fields like Nonalcoholic steatohepatitis, Rifaximin, Randomized controlled trial, Placebo and Obeticholic acid.
His research integrates issues of Chronic liver disease, Steatosis, Metabolic syndrome and Insulin resistance in his study of Nonalcoholic fatty liver disease. The Steatohepatitis study combines topics in areas such as Non alcoholic and Liver biopsy. His Cirrhosis research includes elements of Hepatocellular carcinoma, Clinical trial, Hepatology and Liver transplantation.
Arun J. Sanyal mostly deals with Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Steatohepatitis and Fatty liver. His Internal medicine study combines topics in areas such as Placebo and Endocrinology. His Nonalcoholic fatty liver disease research incorporates elements of Interquartile range, Methylation, Cirrhosis, Hepatic fibrosis and Hepatology.
The study incorporates disciplines such as Body mass index and Liver disease in addition to Cirrhosis. Arun J. Sanyal combines subjects such as Nonalcoholic steatohepatitis, Biopsy, Placebo-controlled study and Confidence interval with his study of Gastroenterology. His Fatty liver study incorporates themes from Chronic liver disease, Prospective cohort study and Obesity, Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl.
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
Onpan Cheung;Puneet Puri;Christoph Eicken;Melissa J. Contos.
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
Douglas M. Heuman;Douglas M. Heuman;Souheil G. Abou-Assi;Souheil G. Abou-Assi;Adil Habib;Adil Habib;Leslie M. Williams.
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
Arun J. Sanyal;Thomas Boyer;Guadalupe Garcia-Tsao;Frederick Regenstein.
Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure.
Stephen C. Strom;Robert A. Fisher;Melissa T. Thompson;Arun J. Sanyal.
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj;Douglas M. Heuman;Phillip B. Hylemon;Arun J. Sanyal.
Journal of Hepatology (2014)
Right lobe living donor liver transplantation.
Amadeo Marcos;Robert A. Fisher;John M. Ham;Mitchell L. Shiffman.
SIMILARITIES AND DIFFERENCES IN OUTCOMES OF CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS AND HEPATITIS C
Arun J. Sanyal;Colin Banas;Carol Sargeant;Velimir A. Luketic.
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
Arun J. Sanyal;Pouneh S. Mofrad;Melissa J. Contos;Carol Sargeant.
Clinical Gastroenterology and Hepatology (2004)
The plasma lipidomic signature of nonalcoholic steatohepatitis.
Puneet Puri;Michelle M. Wiest;Onpan Cheung;Faridoddin Mirshahi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: